HK1248691A1 - 3-甲酰基利福黴素sv的3-(4-肉桂基-1-呱嗪基)氨基衍生物的用途和製備方法 - Google Patents

3-甲酰基利福黴素sv的3-(4-肉桂基-1-呱嗪基)氨基衍生物的用途和製備方法

Info

Publication number
HK1248691A1
HK1248691A1 HK18108267.9A HK18108267A HK1248691A1 HK 1248691 A1 HK1248691 A1 HK 1248691A1 HK 18108267 A HK18108267 A HK 18108267A HK 1248691 A1 HK1248691 A1 HK 1248691A1
Authority
HK
Hong Kong
Prior art keywords
formylrifamycin
cinnamyl
piperazinyl
preparation process
amino derivatives
Prior art date
Application number
HK18108267.9A
Other languages
English (en)
Inventor
R‧G‧康斯坦丁諾瓦
基里爾‧阿瑟諾夫‧尼諾夫
衛理士卡‧里列瓦‧阿波斯托洛娃-迪莫瓦
伊夫提米亞‧伊萬諾瓦‧斯戴凡諾瓦
羅森‧克魯莫夫‧科伊特切夫
Original Assignee
阿迪帕姆單人股份公司
里伊博米爾‧博治達諾夫‧夫杜魯夫
基里爾‧阿瑟諾夫‧尼諾夫
衛理士卡‧里列瓦‧阿波斯托洛娃-迪莫瓦
伊夫提米亞‧伊萬諾瓦‧斯戴凡諾瓦
羅森‧克魯莫夫‧科伊特切夫
迪特切夫諮詢有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿迪帕姆單人股份公司, 里伊博米爾‧博治達諾夫‧夫杜魯夫, 基里爾‧阿瑟諾夫‧尼諾夫, 衛理士卡‧里列瓦‧阿波斯托洛娃-迪莫瓦, 伊夫提米亞‧伊萬諾瓦‧斯戴凡諾瓦, 羅森‧克魯莫夫‧科伊特切夫, 迪特切夫諮詢有限責任公司 filed Critical 阿迪帕姆單人股份公司
Publication of HK1248691A1 publication Critical patent/HK1248691A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Chemistry (AREA)
HK18108267.9A 2012-08-13 2018-06-27 3-甲酰基利福黴素sv的3-(4-肉桂基-1-呱嗪基)氨基衍生物的用途和製備方法 HK1248691A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG11128812 2012-08-13

Publications (1)

Publication Number Publication Date
HK1248691A1 true HK1248691A1 (zh) 2018-10-19

Family

ID=50101135

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15107597.5A HK1206980A1 (zh) 2012-08-13 2015-08-06 包含 -甲酰基利福霉素 -甲酰基利福霉素 -肉桂基- -哌嗪基 氨基衍生物的藥物製劑以及它們的製備方法
HK18108267.9A HK1248691A1 (zh) 2012-08-13 2018-06-27 3-甲酰基利福黴素sv的3-(4-肉桂基-1-呱嗪基)氨基衍生物的用途和製備方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK15107597.5A HK1206980A1 (zh) 2012-08-13 2015-08-06 包含 -甲酰基利福霉素 -甲酰基利福霉素 -肉桂基- -哌嗪基 氨基衍生物的藥物製劑以及它們的製備方法

Country Status (18)

Country Link
US (2) US9682997B2 (zh)
EP (1) EP2882435B8 (zh)
JP (2) JP6400580B2 (zh)
KR (1) KR102210848B1 (zh)
CN (2) CN107840854A (zh)
BR (1) BR112015002945B1 (zh)
CA (1) CA2881958C (zh)
EA (1) EA029363B1 (zh)
ES (1) ES2876004T3 (zh)
HK (2) HK1206980A1 (zh)
HU (1) HUE054955T2 (zh)
IN (1) IN2015DN02009A (zh)
MX (1) MX2015001963A (zh)
PL (1) PL2882435T3 (zh)
PT (1) PT2882435T (zh)
UA (1) UA120030C2 (zh)
WO (1) WO2014026254A1 (zh)
ZA (1) ZA201501268B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020102511A (ru) * 2017-06-26 2021-07-27 Биофер С.П.А. Соединения пиридо-имидазо рифамицина в качестве антибактериального средства
TWI731295B (zh) * 2019-01-24 2021-06-21 宏碁股份有限公司 顯示裝置以及控制顯示裝置的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478563A (en) 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
GR64108B (en) 1977-04-15 1980-01-24 Dso Pharmachim Method for the preparation of azomethine-derivatives of rifamycin s.v
US4179439A (en) * 1977-07-01 1979-12-18 Intreprinderea De Antibiotice Iasi Rifamycins and method for their preparation
US4193020A (en) 1978-05-22 1980-03-11 Sperry Rand Corporation Phase lock control system with trajectory correction
JPS5738742A (en) * 1980-08-21 1982-03-03 Kawasaki Kasei Chem Ltd Preparation of 1,4-dihydroanthraquinone
JPS5695190A (en) * 1980-09-17 1981-08-01 Intorepurinderea De Anteibiote Manufacture of rifamycin derivative
IT1201963B (it) * 1983-03-24 1989-02-02 Prodotti Antibiotici Spa Derivati delle rifamicine e procedimento per la loro preparazione
JPS6143132A (ja) * 1984-08-06 1986-03-01 Takeda Chem Ind Ltd キノン誘導体，その製造法およびそれを含んでなる医薬組成物
WO1987002361A1 (en) * 1985-10-18 1987-04-23 Ciba-Geigy Ag Substituted 4-benzyl-piperazinyl compounds
IT1202424B (it) * 1987-01-26 1989-02-09 Prodotti Antibiotici Spa Sali di un derivato rifamicinico
EP0284552A1 (de) * 1987-03-06 1988-09-28 Ciba-Geigy Ag 4-Benzyl-piperazinyl-Hydrazone
BG48618A1 (en) 1988-02-23 1991-04-15 Nauchen Inst Promishlena Mikro Method for preparing riphampycin
JPH02215716A (ja) * 1989-02-08 1990-08-28 Farmitalia Carlo Erba Spa ３―（ｎ―ピペリジノメチル―アジノ）メチルリファマイシンｓを活性成分として含有する薬剤組成物
US5095108A (en) 1990-08-28 1992-03-10 Technologichen Kombinat Za Promishlena Microbiologia Non-solvated crystalline form "A" of 3-(4-cynnamyl-1-piperazinyl)iminomethylrifamycine SV and a method of its production
BG64021B1 (bg) 1998-11-04 2003-10-31 КОНСТАНТИНОВА Румяна Натриева сол на 3-(4-цинамил-1-пиперазинил)-иминометил рифамицин и метод за получаването й
DE10015814A1 (de) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung
DE10038101A1 (de) * 2000-08-04 2002-02-14 Degussa Verfahren zur Herstellung von 2-(4-Methyl-3-pentenyl)-anthrachinon
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
CN101031572B (zh) * 2004-07-22 2010-12-08 坎布里Ip风险投资有限合伙公司 (r/s)利福霉素衍生物，它们的制备和药物组合物
GB0505909D0 (en) * 2005-03-23 2005-04-27 Univ Leeds Formulations

Also Published As

Publication number Publication date
EP2882435B1 (en) 2021-03-17
WO2014026254A1 (en) 2014-02-20
CN104736152B (zh) 2018-01-23
IN2015DN02009A (zh) 2015-08-14
CN104736152A (zh) 2015-06-24
JP2018199718A (ja) 2018-12-20
KR20150042275A (ko) 2015-04-20
US20150368263A1 (en) 2015-12-24
BR112015002945B1 (pt) 2021-08-31
US9682997B2 (en) 2017-06-20
PL2882435T3 (pl) 2021-10-04
EP2882435B8 (en) 2024-01-03
UA120030C2 (uk) 2019-09-25
HK1206980A1 (zh) 2016-01-22
EP2882435A1 (en) 2015-06-17
KR102210848B1 (ko) 2021-02-02
EP2882435A4 (en) 2017-05-03
HUE054955T2 (hu) 2021-10-28
US20170283433A1 (en) 2017-10-05
JP2015528823A (ja) 2015-10-01
JP6694029B2 (ja) 2020-05-13
CA2881958A1 (en) 2014-02-20
BR112015002945A8 (pt) 2018-01-16
EA029363B1 (ru) 2018-03-30
CN107840854A (zh) 2018-03-27
MX2015001963A (es) 2015-06-04
BR112015002945A2 (pt) 2017-12-05
CA2881958C (en) 2019-08-27
US9981985B2 (en) 2018-05-29
PT2882435T (pt) 2021-06-18
ES2876004T3 (es) 2021-11-11
EA201590278A1 (ru) 2015-07-30
ZA201501268B (en) 2016-01-27
JP6400580B2 (ja) 2018-10-03

Similar Documents

Publication Publication Date Title
ZA201502991B (en) Disubstituted amino acids and methods of preparation and use thereof
IL231386A0 (en) Pyrazoloquinolinone derivatives, their preparation and medical use
EP2721063A4 (en) PCSK9 BINDING POLYPEPTIDES AND METHOD OF USE THEREOF
ZA201300002B (en) Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor
LT2683731T (lt) C4-monometiltriterpenoido dariniai ir jų panaudojimo būdai
HK1198442A1 (zh) 吡唑並嘧啶衍生物、其製備方法及其治療用途
EP2834224A4 (en) PROCESSES FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND SALTS THEREOF
ZA201504167B (en) Processes for the preparation of 4-amino-3-halo-6- (substituted)picolinates and 4-amino-5-fluoro-3-halo-6- (substituted)picolinates
IL227711A0 (en) Phenyl-isoxazole history and their preparation process
HK1188791A1 (zh) 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途
EP2701504A4 (en) Sulindac derivatives, their use and preparation
HK1248691A1 (zh) 3-甲酰基利福黴素sv的3-(4-肉桂基-1-呱嗪基)氨基衍生物的用途和製備方法
ZA201407214B (en) Therapeutic preparation and process for preparing said therapeutic preparation
IL238934A0 (en) Methods for the preparation of phenyloxymethyl-nitro-imidazole derivatives and their use